Propranolol treatment for chylothorax due to diffuse lymphangiomatosis

Pediatr Blood Cancer. 2019 May;66(5):e27592. doi: 10.1002/pbc.27592. Epub 2019 Jan 4.

Authors

Melih Hangul¹, Mehmet Kose¹, Alper Ozcan², Ekrem Unal²

Affiliations

¹ Department of Pediatrics, Division of Pediatric Pulmonology Unit Erciyes University, Kayseri, Turkey.
² Department of Pediatrics, Division of Pediatric Hemtology Oncology Unit Erciyes University, Kayseri, Turkey.

PMID: 30609288
DOI: 10.1002/pbc.27592

No abstract available

Keywords: chylothorax; lymphangiomatosis; propranolol.

Publication types

Case Reports
Letter

MeSH terms

Adrenergic beta-Antagonists / therapeutic use*
Child
Chylothorax / drug therapy*
Chylothorax / etiology
Humans
Lung Diseases / complications
Lung Diseases / congenital*
Lymphangiectasis / complications
Lymphangiectasis / congenital*
Male
Prognosis
Propranolol / therapeutic use*

Substances

Adrenergic beta-Antagonists
Propranolol

Supplementary concepts

Lymphangiectasia, pulmonary, congenital